PL409472A1 - Derivatives of 3-substituted-1-{2-[(4-nitrophenyl)amino]ethyl}urea and 3-substituted-1-{2-[(5-nitropyridin-2-yl)amino]ethyl}urea, method for obtaining them and their application - Google Patents

Derivatives of 3-substituted-1-{2-[(4-nitrophenyl)amino]ethyl}urea and 3-substituted-1-{2-[(5-nitropyridin-2-yl)amino]ethyl}urea, method for obtaining them and their application

Info

Publication number
PL409472A1
PL409472A1 PL409472A PL40947214A PL409472A1 PL 409472 A1 PL409472 A1 PL 409472A1 PL 409472 A PL409472 A PL 409472A PL 40947214 A PL40947214 A PL 40947214A PL 409472 A1 PL409472 A1 PL 409472A1
Authority
PL
Poland
Prior art keywords
general formula
ethyl
substituted
amino
urea
Prior art date
Application number
PL409472A
Other languages
Polish (pl)
Other versions
PL229434B1 (en
Inventor
Tomasz Wróbel
Michał Kiełbus
Dariusz Matosiuk
Andrzej Stepulak
Sylwia Król
Original Assignee
Uniwersytet Medyczny W Lublinie
Uniwersytet Marii Curie-Skłodowskiej
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny W Lublinie, Uniwersytet Marii Curie-Skłodowskiej filed Critical Uniwersytet Medyczny W Lublinie
Priority to PL409472A priority Critical patent/PL229434B1/en
Publication of PL409472A1 publication Critical patent/PL409472A1/en
Publication of PL229434B1 publication Critical patent/PL229434B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Przedmiotem wynalazku są nowe pochodne 3-podstawione-1-{2-[(4-nitrofenylo)amino]etylo}mocznika o wzorze ogólnym 1, gdzie R oznacza 1-naftyl, 4-acetylofenyl, 4-chlorobenzyl, 4-metoksybenzyl oraz nowe pochodne 3-podstawione-1-{2-[(5-nitropirydyn-2-ylo)amino]etylo}mocznika o wzorze ogólnym 2, gdzie R oznacza 1-naftyl, 3,4-dichlorofenyl, 4-acetylofenyl, 4-chlorobenzyl, metyl, 4-metoksybenzyl, 4-metoksyfenyl oraz sposób ich otrzymywania. Związki o wzorze ogólnym 1 oraz związki o wzorze ogólnym 2 otrzymuje się w reakcji odpowiednio podstawionymi izocyjanianami o wzorze ogólnym 3, gdzie R oznacza 1-naftyl, 4-acetylofenyl, 4-chlorobenzyl, 4-metoksybenzyl, 3,4-dichlorofenyl, 4-metoksyfenyl. Związek o wzorze ogólnym 2, gdzie R oznacza metyl otrzymuje się w reakcji z N-metylo-1H-imidazolo-1-karboksamidem z dodatkiem zasady organicznej. Reakcje prowadzi się w temperaturze pokojowej dobierając reagenty w stosunku molowym 1:1. Wydzielony osad oczyszcza się przez krystalizację z polarnego rozpuszczalnika, korzystnie z propan-2-olu, 1,4-dioksanu, kwasu octowego lub metodą chromatografii kolumnowej z użycie krzemionki i mieszaniny octanu etylu z heksanem. Ujawnione związki mogą znaleźć zastosowanie w leczeniu wybranych nowotworów.The present invention relates to new 3-substituted-1- {2 - [(4-nitrophenyl) amino] ethyl} urea derivatives of general formula 1, where R is 1-naphthyl, 4-acetylphenyl, 4-chlorobenzyl, 4-methoxybenzyl and new 3-substituted-1- {2 - [(5-nitropyridin-2-yl) amino] ethyl} urea derivatives of general formula 2 where R is 1-naphthyl, 3,4-dichlorophenyl, 4-acetylphenyl, 4-chlorobenzyl , methyl, 4-methoxybenzyl, 4-methoxyphenyl and the method of their preparation. Compounds of general formula 1 and compounds of general formula 2 are obtained by reacting appropriately substituted isocyanates of general formula 3, where R is 1-naphthyl, 4-acetylphenyl, 4-chlorobenzyl, 4-methoxybenzyl, 3,4-dichlorophenyl, 4- methoxyphenyl. The compound of general formula 2 where R is methyl is obtained by reaction with N-methyl-1H-imidazole-1-carboxamide with the addition of an organic base. The reactions are carried out at room temperature, selecting reagents in a 1: 1 molar ratio. The precipitate formed is purified by crystallization from a polar solvent, preferably propan-2-ol, 1,4-dioxane, acetic acid or by column chromatography using silica and a mixture of ethyl acetate and hexane. The disclosed compounds may find use in the treatment of selected cancers.

PL409472A 2014-09-11 2014-09-11 Derivatives of 3-substituted-1-{2-[(4-nitrophenyl)amino]ethyl}urea and 3-substituted-1-{2-[(5-nitropyridin-2-yl)amino]ethyl}urea, method for obtaining them and their application PL229434B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL409472A PL229434B1 (en) 2014-09-11 2014-09-11 Derivatives of 3-substituted-1-{2-[(4-nitrophenyl)amino]ethyl}urea and 3-substituted-1-{2-[(5-nitropyridin-2-yl)amino]ethyl}urea, method for obtaining them and their application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL409472A PL229434B1 (en) 2014-09-11 2014-09-11 Derivatives of 3-substituted-1-{2-[(4-nitrophenyl)amino]ethyl}urea and 3-substituted-1-{2-[(5-nitropyridin-2-yl)amino]ethyl}urea, method for obtaining them and their application

Publications (2)

Publication Number Publication Date
PL409472A1 true PL409472A1 (en) 2016-03-14
PL229434B1 PL229434B1 (en) 2018-07-31

Family

ID=55450856

Family Applications (1)

Application Number Title Priority Date Filing Date
PL409472A PL229434B1 (en) 2014-09-11 2014-09-11 Derivatives of 3-substituted-1-{2-[(4-nitrophenyl)amino]ethyl}urea and 3-substituted-1-{2-[(5-nitropyridin-2-yl)amino]ethyl}urea, method for obtaining them and their application

Country Status (1)

Country Link
PL (1) PL229434B1 (en)

Also Published As

Publication number Publication date
PL229434B1 (en) 2018-07-31

Similar Documents

Publication Publication Date Title
ES2811329T3 (en) Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors
CY1123670T1 (en) 6,7-UNSATURATED-7-CARBAMOYL MORPFINANE CRYSTALLINE DERIVATIVE, AND METHOD FOR THE PRODUCTION THEREOF
AR083213A1 (en) PREPARATION PROCESS OF PYRIMIDINIC DERIVATIVES, INTERMEDIATE COMPOUNDS AND PROCESS TO PREPARE THEM
BRPI0516911A (en) method for the preparation of an aniline compound and compound
RS54199B1 (en) Process for preparing intermediates of compounds useful as opioid receptor modulators
NO20091858L (en) Hydrobenzamide derivatives as inhibitors of HSP90
EA201301315A1 (en) METHOD FOR OBTAINING INTERMEDIATE COMPOUNDS OF ESTHETROL
JP2012524726A5 (en)
JP6394690B2 (en) Process for producing 1,1-disubstituted hydrazine compounds
AR117002A2 (en) PROCESS FOR THE PREPARATION OF KINASE C-FMS INHIBITORS
DK1723140T3 (en) Process for the preparation of tryptase inhibitors
MX2022001495A (en) Novel processes for preparation of soluble guanylate cyclase stimulators.
DK1877370T3 (en) Process for Preparation of Hydrazone Derivatives
JP2016190818A (en) Method for producing 1,1-disubstituted hydrazine compounds
AR051936A1 (en) PROCESS FOR THE PREPARATION OF PIRAZOLES
DE602006020196D1 (en) PROCESS FOR PREPARING A 3-O-ALKYLASCORBIC ACID
PL409472A1 (en) Derivatives of 3-substituted-1-{2-[(4-nitrophenyl)amino]ethyl}urea and 3-substituted-1-{2-[(5-nitropyridin-2-yl)amino]ethyl}urea, method for obtaining them and their application
AR077332A1 (en) PROCESSES FOR THE RENTAL OF PIRAZOLES
EA201991887A1 (en) SUBSTITUTED ETHERS OF BENZYL-4-AMINOPICOLIC ACID AND ETHERS OF PYRIMIDIN-4-CARBOXYLIC ACID, METHODS FOR PRODUCING THEM, AND ALSO APPLICATION AS HERBICIDES AND REGULATORS
EA201390536A1 (en) METHOD OF SYNTHESIS OF CYCLIC CARBAMATES
JP6994498B2 (en) Method for preparing 3-amino-1- (2,6-disubstituted phenyl) pyrazoles
KR101580821B1 (en) Development of a New Synthetic Method for Quinazolinones via Aerobic Oxidation in dimethylsulfoxide
BR112015021072A2 (en) process for preparing an isohexide monotriflate, chemical compound, process for making a compound derived from an isohexide monotriflate, and, derivative compound
JP6466107B2 (en) 4-Phenylthio-5- (trifluoromethyl) pyrimidine derivative and method for producing the same
JP2014227349A (en) Method for producing heterocyclic compound